Oral manifestations produced by the consumption of drugs administered within the palliative treatment of Covid-19: bibliographic review.

Abstract

Introduction: Coronavirus (Covid-19) is a microscopic acellular infectious agent; considered as a respiratory virus that begins its infection from the throat when it enters our body; by means of the eyes, mouth or nose it is possible to hold the mucosa cells particularly from the nose and throat; This virus has the ability to replicate, because once the copies are made they leave the cell where they originated, destroy it and begin to infect other cells. Objective: To identify the oral manifestations produced by the consumption of drugs administered within the palliative treatment of COVID-19. Materials and Methods: This study is descriptive, cross-sectional, retrospective. Conclusion: The research carried out determines that the consumption of drugs implemented for the palliative treatment of COVID-19, such as Hydroxychloroquine, Chloroquine and Remdesivir, produce manifestations in the oral cavity such as dental abrasion, pigmentation, xerostomia and lichen planus.